World Imaging Biomarkers Market: Encouraging Pace of Healthcare Infrastructure Development to Drive Growth across Asia Pacific; Regional Outlook 2023

The global market for imaging biomarker is the focus of analysis of a recent market research report by Transparency Market Research. The detailed report examines the present state of the market and presents a thorough forecast regarding the growth prospects of the key market segments and regional markets. The report is titled “Imaging Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023.”

The market is chiefly driven by the rising prevalence of a variety of cancers across the globe. Biomarkers are known to be of great help in the early detection of cancer, leading to a promising rise in rate of survival among patients. The American Cancer Society states that by 2030, the number of cancer cases will rise to nearly 21.4 mn by 2030. 13.2 mn deaths will result directly from cancer and related complications by the said year.

Read Full Report: http://www.transparencymarketresearch.com/imaging-biomarkers-market.html

This scenario will lead to a significant rise in demand for technologies that can provide key insights into the cancer etiology and can effectively diagnose, detect, and treat cancer. As a result, the market for imaging biomarkers will gain significant impetus in the near future due to the key role played by imaging biomarkers in the detection of cancer.

For the report, the global imaging biomarkers market has been segmented based on criteria such as application, imaging technology, and geography. In terms of imaging technologies, the report examines segments such as computed tomography (CT), positron emission tomography (PET), ultrasound, and magnetic resonance imaging (MRI).

Geographically, the global imaging biomarkers market is dominated by developed regions such as North America and Europe. The well-established and technologically healthcare infrastructure in these regions is the key factor fueling the growth of the imaging biomarkers market. Thanks to extensive investments poured in for R&D activities, the markets for imaging biomarkers across these regions are expected to exhibit strong growth over the forecast period as well.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2381

Nevertheless, the market is expected to exhibit the most promising growth in Asia Pacific over the forecast period. Factors such as improvement in the healthcare infrastructure, rising expenditure on health and wellness, and rising awareness regarding the importance of regular health checkups among the masses will be the key factors aiding the growth of the Asia Pacific imaging biomarkers market in the next few years.

The vendor landscape of the global imaging biomarkers market features the presence of a large number of regional and international players. Some of the key vendors in the market are Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Company, Gen-Probe Inc., Biocrates Life Sciences AG, Danaher Corporation, DiagnoCure, Inc., F. Hoffmann La Roche Ltd., Qiagen NV, and Siemens Healthcare.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.